These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 37820705)

  • 1. Cannabidiol for the Treatment of Pediatric Epilepsy.
    Daniel J
    Pediatr Ann; 2023 Oct; 52(10):e369-e372. PubMed ID: 37820705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy: A potential role for infantile spasms and Lennox-Gastaut syndrome.
    Hussain SA; Zhou R; Jacobson C; Weng J; Cheng E; Lay J; Hung P; Lerner JT; Sankar R
    Epilepsy Behav; 2015 Jun; 47():138-41. PubMed ID: 25935511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy.
    Porter BE; Jacobson C
    Epilepsy Behav; 2013 Dec; 29(3):574-7. PubMed ID: 24237632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of artisanal preparations of cannabidiol for the treatment of epilepsy: Practical experiences in a tertiary medical center.
    Porcari GS; Fu C; Doll ED; Carter EG; Carson RP
    Epilepsy Behav; 2018 Mar; 80():240-246. PubMed ID: 29429908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Pharmacological Basis of Cannabis Therapy for Epilepsy.
    Reddy DS; Golub VM
    J Pharmacol Exp Ther; 2016 Apr; 357(1):45-55. PubMed ID: 26787773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabidiol for Epilepsy: New Hope on the Horizon?
    Sanmartin PE; Detyniecki K
    Clin Ther; 2018 Sep; 40(9):1438-1441. PubMed ID: 30150078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical Marijuana in the Pediatric Population With Epilepsy-What You Should Know.
    Markle M; Nativio DG
    J Pediatr Health Care; 2019; 33(6):626-632. PubMed ID: 31160106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabis for the Treatment of Epilepsy: an Update.
    Gaston TE; Szaflarski JP
    Curr Neurol Neurosci Rep; 2018 Sep; 18(11):73. PubMed ID: 30194563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabis and Endocannabinoid Signaling in Epilepsy.
    Katona I
    Handb Exp Pharmacol; 2015; 231():285-316. PubMed ID: 26408165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection.
    Rosenberg EC; Patra PH; Whalley BJ
    Epilepsy Behav; 2017 May; 70(Pt B):319-327. PubMed ID: 28190698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabis and epilepsy.
    Thomas RH; Cunningham MO
    Pract Neurol; 2018 Dec; 18(6):465-471. PubMed ID: 30337476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic and clinical foundations of cannabidiol therapy for difficult-to-treat seizures in children and adults with refractory epilepsies.
    Reddy DS
    Exp Neurol; 2023 Jan; 359():114237. PubMed ID: 36206806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosage of cannabidiol-enriched cannabis in children and adults with epilepsy.
    Cohen H; Kramer U; Hausman-Kedem M; Uliel-Siboni S; Eyal S
    Brain Dev; 2021 Sep; 43(8):890-891. PubMed ID: 34226095
    [No Abstract]   [Full Text] [Related]  

  • 14. Cannabidiol Therapy for Refractory Epilepsy and Seizure Disorders.
    Golub V; Reddy DS
    Adv Exp Med Biol; 2021; 1264():93-110. PubMed ID: 33332006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical aspects and therapeutic mechanisms of cannabidiol in epilepsy.
    Boleti APA; Frihling BEF; E Silva PS; Cardoso PHO; de Moraes LFRN; Rodrigues TAA; Biembengute MEF; Koolen HHF; Migliolo L
    Neurosci Biobehav Rev; 2022 Jan; 132():1214-1228. PubMed ID: 33031814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marijuana use among patients with epilepsy at a tertiary care center.
    Kerr A; Walston V; Wong VSS; Kellogg M; Ernst L
    Epilepsy Behav; 2019 Aug; 97():144-148. PubMed ID: 31252269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabinoids in epilepsy: clinical efficacy and pharmacological considerations.
    Espinosa-Jovel C
    Neurologia (Engl Ed); 2023; 38(1):47-53. PubMed ID: 34824031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabidiol-enriched oil in children and adults with treatment-resistant epilepsy-does tolerance exist?
    Uliel-Sibony S; Hausman-Kedem M; Fattal-Valevski A; Kramer U
    Brain Dev; 2021 Jan; 43(1):89-96. PubMed ID: 32713661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders.
    Devinsky O; Cilio MR; Cross H; Fernandez-Ruiz J; French J; Hill C; Katz R; Di Marzo V; Jutras-Aswad D; Notcutt WG; Martinez-Orgado J; Robson PJ; Rohrback BG; Thiele E; Whalley B; Friedman D
    Epilepsia; 2014 Jun; 55(6):791-802. PubMed ID: 24854329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Utility of Cannabidiol in the Treatment of Refractory Epilepsy.
    Reddy DS
    Clin Pharmacol Ther; 2017 Feb; 101(2):182-184. PubMed ID: 27506704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.